Belief BioMed (BBM) today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially ...

Foundational research led by co-founder Justin Eyquem, Ph.D., underpins Azalea’s proprietary in vivo CAR T platformPeer-reviewed publication ...

WEST LAFAYETTE, IN, UNITED STATES, March 5, 2026 /EINPresswire.com/ -- Advancing Agricultural Excellence Through Plant ...

Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. The Company’s clinical-stage programs consist of a ...

Strasbourg, France, January 23, 2026, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced ...

Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, government agencies, and the general public for decades. GMOs are banned in some ...

Comprehensive immunogenicity data of individualized neoantigen therapeutic vaccine (INTV) TG4050, from the randomized Phase I study in operable Head and Neck Squamous Cell Carcinoma (HNSCC) patients, ...

Good day, and thank you for standing by. Welcome to the Transgene 2025 Half Year Financial Results Conference Call and Webcast. [Operator Instructions] After the speaker's presentation, there will be ...

Conference call scheduled today at 6 p.m. CET (in English). See details below. Strasbourg, France, September 16, 2025, 5:45 pm CET — Transgene (Euronext Paris: TNG), a biotech company that designs and ...

The nanoparticles are composed of multiferric cores (Cobalt ferrite and Bismuth ferrite which responsive to magnetic field) and chitosan outer layers (which is rich in positive amino group for ...

Transgene and ProBioGen, a CDMO, inked a license agreement for ProBioGen’s AGE1.CR.pIX ® suspension cell line which will combine ProBioGen’s specific production technology with the manufacturing ...